Sign In
Buy SIBN
$15.84
+0.630 (+4.14%)
At Close: Jun 18, 2026
Si-Bone (SIBN) Reports Q1 Loss, Tops Revenue Estimates
06:26pm, Monday, 06'th May 2024
Si-Bone (SIBN) came out with a quarterly loss of $0.27 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to loss of $0.32 per share a year ago.
SI-BONE, Inc. Reports Financial Results for the First Quarter 2024
04:09pm, Monday, 06'th May 2024
Annual guidance increased to $164 million - $166 million, implying annual growth of ~18% - 20% Annual guidance increased to $164 million - $166 million, implying annual growth of ~18% - 20%
Si-Bone (SIBN) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
11:06am, Monday, 29'th Apr 2024
Si-Bone (SIBN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SI-BONE To Present at BofA Securities 2024 Healthcare Conference on May 14, 2024
09:00am, Monday, 29'th Apr 2024
SANTA CLARA, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announce
SI-BONE To Report First Quarter 2024 Financial Results on May 6, 2024
04:09pm, Monday, 15'th Apr 2024
SANTA CLARA, Calif., April 15, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy today announced
SI-BONE to Present at Barclays 26th Annual Global Healthcare Conference on March 12, 2024
04:09pm, Monday, 04'th Mar 2024
SANTA CLARA, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announce
SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Guidance
04:09pm, Monday, 26'th Feb 2024
SANTA CLARA, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported
Si-Bone (SIBN) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
11:05am, Monday, 19'th Feb 2024
Si-Bone (SIBN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SI-BONE To Report Fourth-Quarter and Full-Year 2023 Financial Results on February 26, 2024
04:09pm, Monday, 05'th Feb 2024
SANTA CLARA, Calif., Feb. 05, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:51am, Wednesday, 31'st Jan 2024
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
SANTA CLARA, Calif., Jan. 30, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic an
SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2023
08:30am, Monday, 08'th Jan 2024
Fiscal Year 2023 revenue of $138.5 - $138.7 million representing growth of over 30% Fiscal Year 2023 revenue of $138.5 - $138.7 million representing growth of over 30%
Si-Bone (SIBN) Crossed Above the 50-Day Moving Average: What That Means for Investors
10:31am, Thursday, 30'th Nov 2023
Si-Bone (SIBN) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, SIBN broke out above the 50-day moving average, suggesting a s
Sizing Up SI-BONE After Q3 Earnings
12:47pm, Thursday, 16'th Nov 2023
Today, we take a look at SI-BONE, Inc., a medical device company focused on developing implantable devices for musculoskeletal disorders. The company is targeting a large potential market, delivers co
SI-BONE To Present at Piper Sandler 35th Annual Healthcare Conference on November 28, 2023
04:09pm, Tuesday, 14'th Nov 2023
SANTA CLARA, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced
